Delivery Order SPE2DB20D3104-SPE2DB25FV6C7

Award Date 3/28/25
Potential Completion Date 3/31/25
Potential Value $5.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,504.58, is for the delivery of AIMOVIG 140 MG/ML autoinjectors. The award has a firm fixed price pricing type and an ultimate completion date of March 1, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,155.60 firm-fixed-price contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTOR medical products. The award has an ultimate completion date of January 14, 2025. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,360.46, is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a medical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has a ceiling value of $5,162.97 and an ultimate completion date of August 12, 2024. The contract is a firm-fixed-price delivery order, without any set-aside designation. AmerisourceBergen, as the prime contractor, will be responsible for providing the specified pharmaceutical item to support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $5,829.16 firm fixed-price contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty pharmaceutical product. The ultimate completion date for this delivery order is October 21, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,738.87 and runs through January 31, 2025. The award is for the supply of AIMOVIG 140 MG/ML AUTOINJECTOR, a specialty medication. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,209.32 delivery order contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTOR medical products. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a comprehensive vehicle for providing...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,519.08, is for the procurement of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty medication. The contract is a firm fixed-price, delivery order with an ultimate completion date of March 12, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a larger...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,758.34, is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a prescription medication. The contract has an ultimate completion date of April 18, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,647.48, is for the supply of AIMOVIG 140 MG/ML autoinjectors. It is a firm fixed-price contract with a completion date of February 20, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB25FV6C7
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,453.18, is for the delivery of AIMOVIG 70 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of March 31, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 6/27/25, 11:50 AM